Your browser doesn't support javascript.
loading
Inhaled Nitric Oxide (iNO) and Inhaled Epoprostenol (iPGI2) Use in Cardiothoracic Surgical Patients: Is there Sufficient Evidence for Evidence-Based Recommendations?
Rao, Vidya; Ghadimi, Kamrouz; Keeyapaj, Worasak; Parsons, Cody A; Cheung, Albert T.
Affiliation
  • Rao V; Department of Anesthesiology, Stanford University, Stanford, CA.
  • Ghadimi K; Department of Anesthesiology, Duke University Medical Center, Durham, NC.
  • Keeyapaj W; Department of Anesthesiology, Stanford University, Stanford, CA.
  • Parsons CA; Stanford Health Care, Stanford, CA.
  • Cheung AT; Department of Anesthesiology, Stanford University, Stanford, CA. Electronic address: ATCheung@stanford.edu.
J Cardiothorac Vasc Anesth ; 32(3): 1452-1457, 2018 06.
Article in En | MEDLINE | ID: mdl-29336971

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epoprostenol / Cost-Benefit Analysis / Evidence-Based Medicine / Anesthesia, Cardiac Procedures / Cardiac Surgical Procedures / Nitric Oxide Type of study: Clinical_trials Limits: Humans Language: En Journal: J Cardiothorac Vasc Anesth Journal subject: ANESTESIOLOGIA / CARDIOLOGIA Year: 2018 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Epoprostenol / Cost-Benefit Analysis / Evidence-Based Medicine / Anesthesia, Cardiac Procedures / Cardiac Surgical Procedures / Nitric Oxide Type of study: Clinical_trials Limits: Humans Language: En Journal: J Cardiothorac Vasc Anesth Journal subject: ANESTESIOLOGIA / CARDIOLOGIA Year: 2018 Document type: Article Affiliation country: Canada Country of publication: United States